ChemoMetec A/S (CPH: CHEMM)
Denmark flag Denmark · Delayed Price · Currency is DKK
491.00
-0.80 (-0.16%)
Dec 20, 2024, 4:59 PM CET

ChemoMetec Statistics

Total Valuation

ChemoMetec has a market cap or net worth of DKK 8.54 billion. The enterprise value is 8.25 billion.

Market Cap 8.54B
Enterprise Value 8.25B

Important Dates

The next estimated earnings date is Wednesday, February 5, 2025.

Earnings Date Feb 5, 2025
Ex-Dividend Date Oct 11, 2024

Share Statistics

ChemoMetec has 17.40 million shares outstanding.

Current Share Class n/a
Shares Outstanding 17.40M
Shares Change (YoY) n/a
Shares Change (QoQ) -0.22%
Owned by Insiders (%) 0.36%
Owned by Institutions (%) 50.65%
Float 17.34M

Valuation Ratios

The trailing PE ratio is 62.71 and the forward PE ratio is 46.54. ChemoMetec's PEG ratio is 9.50.

PE Ratio 62.71
Forward PE 46.54
PS Ratio 20.95
PB Ratio 15.11
P/TBV Ratio 18.15
P/FCF Ratio 79.08
P/OCF Ratio n/a
PEG Ratio 9.50
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 46.16, with an EV/FCF ratio of 76.37.

EV / Earnings 60.55
EV / Sales 20.23
EV / EBITDA 46.16
EV / EBIT 48.84
EV / FCF 76.37

Financial Position

The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.01.

Current Ratio 4.97
Quick Ratio 3.71
Debt / Equity 0.01
Debt / EBITDA 0.02
Debt / FCF 0.04
Interest Coverage 923.31

Financial Efficiency

Return on equity (ROE) is 24.82% and return on invested capital (ROIC) is 19.03%.

Return on Equity (ROE) 24.82%
Return on Assets (ROA) 15.82%
Return on Capital (ROIC) 19.03%
Revenue Per Employee 2.34M
Profits Per Employee 783,241
Employee Count 174
Asset Turnover 0.61
Inventory Turnover 0.35

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +16.24% in the last 52 weeks. The beta is 1.31, so ChemoMetec's price volatility has been higher than the market average.

Beta (5Y) 1.31
52-Week Price Change +16.24%
50-Day Moving Average 449.47
200-Day Moving Average 389.14
Relative Strength Index (RSI) 56.44
Average Volume (20 Days) 40,733

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ChemoMetec had revenue of DKK 407.87 million and earned 136.28 million in profits. Earnings per share was 7.83.

Revenue 407.87M
Gross Profit 367.60M
Operating Income 168.97M
Pretax Income 176.59M
Net Income 136.28M
EBITDA 178.78M
EBIT 168.97M
Earnings Per Share (EPS) 7.83
Full Income Statement

Balance Sheet

The company has 296.15 million in cash and 4.16 million in debt, giving a net cash position of 291.99 million or 16.78 per share.

Cash & Cash Equivalents 296.15M
Total Debt 4.16M
Net Cash 291.99M
Net Cash Per Share 16.78
Equity (Book Value) 565.32M
Book Value Per Share 32.48
Working Capital 391.27M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 129.00 million and capital expenditures -20.95 million, giving a free cash flow of 108.06 million.

Operating Cash Flow 129.00M
Capital Expenditures -20.95M
Free Cash Flow 108.06M
FCF Per Share 6.21
Full Cash Flow Statement

Margins

Gross margin is 90.13%, with operating and profit margins of 41.43% and 33.41%.

Gross Margin 90.13%
Operating Margin 41.43%
Pretax Margin 43.29%
Profit Margin 33.41%
EBITDA Margin 43.83%
EBIT Margin 41.43%
FCF Margin 26.49%

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.81%.

Dividend Per Share 4.00
Dividend Yield 0.81%
Dividend Growth (YoY) -33.33%
Years of Dividend Growth 1
Payout Ratio 76.62%
Buyback Yield n/a
Shareholder Yield 0.81%
Earnings Yield 1.59%
FCF Yield 1.26%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ChemoMetec has an Altman Z-Score of 38.72.

Altman Z-Score 38.72
Piotroski F-Score n/a